Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Nirmatrelvir (PF-07321332) 300 mg + Ritonavir 100 mg 5 Days	921
Overall Study	STARTED	Nirmatrelvir (PF-07321332) 300 mg + Ritonavir 100 mg 10 Days	917
Overall Study	STARTED	Placebo	898
Overall Study	Treated	Nirmatrelvir (PF-07321332) 300 mg + Ritonavir 100 mg 5 Days	913
Overall Study	Treated	Nirmatrelvir (PF-07321332) 300 mg + Ritonavir 100 mg 10 Days	911
Overall Study	Treated	Placebo	897
Overall Study	COMPLETED	Nirmatrelvir (PF-07321332) 300 mg + Ritonavir 100 mg 5 Days	877
Overall Study	COMPLETED	Nirmatrelvir (PF-07321332) 300 mg + Ritonavir 100 mg 10 Days	864
Overall Study	COMPLETED	Placebo	863
Overall Study	NOT COMPLETED	Nirmatrelvir (PF-07321332) 300 mg + Ritonavir 100 mg 5 Days	44
Overall Study	NOT COMPLETED	Nirmatrelvir (PF-07321332) 300 mg + Ritonavir 100 mg 10 Days	53
Overall Study	NOT COMPLETED	Placebo	35

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05047601/flow